TranS1 Surges in Public Debut
Editor's Note: In this feature from Stockpickr, we highlight lists of stocks that have been upgraded or downgraded by analysts or are experiencing activist-investor situations or some other market-moving events.
: Reinvigorated buyout rumors moved
Marriott
(MAR) - Get Report
. Recent consolidation in the hotel industry has prompted speculation that Marriott could be the next target of a private equity bid. Shares of Marriott were trading down 2.1% at $41.25 Wednesday after climbing Tuesday.
:
JPMorgan Chase
(JPM) - Get Report
delivered a
solid earnings beat
Wednesday. The bank posted third-quarter earnings of 97 cents a share, 7 cents higher than Wall Street's consensus estimate. The strong results sent shares north 2.4% to $46.20 in recent trading.
TranS1
( TSON) debuted with a flourish on the
Nasdaq
Wednesday. Shares of the medical device company -- which priced 5.5 million shares at $15, above the expected $12 to $14 range -- are now trading more than 60% higher at $24.40.
: Cowen downgraded
Level 3
(LVLT)
from outperform to neutral and also cut its estimates, as acquisitions are taking longer than expected to integrate. Shares of the communication services company recently fell 2.1% to $4.17.
: Deutsche Bank upgraded
US Steel
(X) - Get Report
with a buy rating and raised its price target to $130. The bank also raised its 2008 earnings estimate to $13 a share to reflect rising steel prices. Shares of the steelmaker were climbing 2.1% to $106.58 in recent trading.
: The Children's Investment Master Fund, a 4.1% shareholder in
CSX Corp.
(CSX) - Get Report
, is pressuring the railroad's board of directors to improve the company's business performance. The activist fund is requesting that the chairman and CEO roles be separated and the board "refreshed" with new independent directors. Shares of CSX shot up 6% to $45.40.
Stockpickr is a wholly owned subsidiary of TheStreet.com.